Literature DB >> 15474144

Statistical dissection of cytogenetic patterns in lung cancer reveals multiple modes of karyotypic evolution independent of histological classification.

Mattias Höglund1, David Gisselsson, Gunnar B Hansen, Felix Mitelman.   

Abstract

Lung carcinomas are cytogenetically highly complex. In spite of this, patterns of recurrent chromosome aberrations have emerged. Apart from the frequent loss of 3p, losses of 4q, 5q, 8p, 9p, 10q, 13q, and 17p are common and gains often include 1q, 3q, 5p, and 8q. In the present study, we retrieved all aberrant lung carcinoma karyotypes, in total 432 cases, from the Mitelman Database of Chromosome Aberrations in Cancer and identified the most frequent imbalances. Each case was then classified with respect to the presence or absence of these imbalances and the data were statistically analyzed by means of principal component analysis, multidimensional scaling, and hierarchical cluster analysis. The analyses suggest that lung cancer develops through three pathways, initiated by +7, 3p-, and +12, respectively, and that the 3p- pathway is dominated by losses and the +12 pathway by gains. Gain of chromosome 7 was shown to be both important in the 3p- pathway and also forming a group of tumors containing +7 and +20 (with few additional changes). The distribution of the number of imbalances per tumor indicated that the karyotypic evolution might pass through three different phases. Phase I is characterized by tumors with few changes and by well-separated 3p- and +12 pathways. Phase II cases have an increased number of imbalances and exhibit less distinct 3p- and +12 pathways. Phase III tumors are polyploid and highly complex. No marked differences between the karyotypic profiles were found among morphologic subtypes, suggesting that lung cancer morphology is independent of the particular cytogenetic pathway operating in the tumor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474144     DOI: 10.1016/j.cancergencyto.2004.01.030

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

2.  Overexpression of MEOX2 and TWIST1 is associated with H3K27me3 levels and determines lung cancer chemoresistance and prognosis.

Authors:  Federico Ávila-Moreno; Leonel Armas-López; Aldo M Álvarez-Moran; Zoila López-Bujanda; Blanca Ortiz-Quintero; Alfredo Hidalgo-Miranda; Francisco Urrea-Ramírez; R María Rivera-Rosales; Eugenia Vázquez-Manríquez; Erika Peña-Mirabal; José Morales-Gómez; Juan C Vázquez-Minero; José L Téllez-Becerra; Roberto Ramírez-Mendoza; Alejandro Ávalos-Bracho; Enrique Guzmán de Alba; Karla Vázquez-Santillán; Vilma Maldonado-Lagunas; Patricio Santillán-Doherty; Patricia Piña-Sánchez; Joaquin Zúñiga-Ramos
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

3.  Active centromere and chromosome identification in fixed cell lines.

Authors:  Thian T Beh; Ruth N MacKinnon; Paul Kalitsis
Journal:  Mol Cytogenet       Date:  2016-03-22       Impact factor: 2.009

4.  A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence.

Authors:  Eirini-Stavroula Komseli; Ioannis S Pateras; Thorbjørn Krejsgaard; Konrad Stawiski; Sophia V Rizou; Alexander Polyzos; Fani-Marlen Roumelioti; Maria Chiourea; Ioanna Mourkioti; Eleni Paparouna; Christos P Zampetidis; Sentiljana Gumeni; Ioannis P Trougakos; Dafni-Eleftheria Pefani; Eric O'Neill; Sarantis Gagos; Aristides G Eliopoulos; Wojciech Fendler; Dipanjan Chowdhury; Jiri Bartek; Vassilis G Gorgoulis
Journal:  BMC Genomics       Date:  2018-01-10       Impact factor: 3.969

5.  Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets.

Authors:  Jinyun Chen; Xifeng Wu; Yujing Huang; Wei Chen; Randall E Brand; Ann M Killary; Subrata Sen; Marsha L Frazier
Journal:  Oncotarget       Date:  2016-08-30

6.  ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells.

Authors:  Jan S Moreb; Henry V Baker; Lung-Ji Chang; Maria Amaya; M Cecilia Lopez; Blanca Ostmark; Wayne Chou
Journal:  Mol Cancer       Date:  2008-11-24       Impact factor: 27.401

7.  Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung.

Authors:  Ji Un Kang; Sun Hoe Koo; Kye Chul Kwon; Jong Woo Park; Jin Man Kim
Journal:  BMC Cancer       Date:  2009-07-16       Impact factor: 4.430

8.  CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells.

Authors:  Jinping Jia; Allen D Bosley; Abbey Thompson; Jason W Hoskins; Adam Cheuk; Irene Collins; Hemang Parikh; Zhen Xiao; Kris Ylaya; Marta Dzyadyk; Wendy Cozen; Brenda Y Hernandez; Charles F Lynch; Jadranka Loncarek; Sean F Altekruse; Lizhi Zhang; Christopher J Westlake; Valentina M Factor; Snorri Thorgeirsson; William R Bamlet; Stephen M Hewitt; Gloria M Petersen; Thorkell Andresson; Laufey T Amundadottir
Journal:  Cancer Res       Date:  2014-03-19       Impact factor: 13.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.